| Code | Display | Comments |
|---|
 A | ALIMENTARY TRACT AND METABOLISM | |
| A01 | STOMATOLOGICAL PREPARATIONS | |
| A01A | STOMATOLOGICAL PREPARATIONS | |
| A01AA | Caries prophylactic agents | |
| A01AA01 | sodium fluoride | |
| A01AA02 | sodium monofluorophosphate | |
| A01AA03 | olaflur | |
| A01AA04 | stannous fluoride | |
| A01AA30 | combinations | |
| A01AA51 | sodium fluoride, combinations | |
| A01AB | Antiinfectives and antiseptics for local oral treatment | |
| A01AB02 | hydrogen peroxide | |
| A01AB03 | chlorhexidine | |
| A01AB04 | amphotericin B | |
| A01AB05 | polynoxylin | |
| A01AB06 | domiphen | |
| A01AB07 | oxyquinoline | |
| A01AB08 | neomycin | |
| A01AB09 | miconazole | |
| A01AB10 | natamycin | |
| A01AB11 | various | |
| A01AB12 | hexetidine | |
| A01AB13 | tetracycline | |
| A01AB14 | benzoxonium chloride | |
| A01AB15 | tibezonium iodide | |
| A01AB16 | mepartricin | |
| A01AB17 | metronidazole | |
| A01AB18 | clotrimazole | |
| A01AB19 | sodium perborate | |
| A01AB21 | chlortetracycline | |
| A01AB22 | doxycycline | |
| A01AB23 | minocycline | |
| A01AC | Corticosteroids for local oral treatment | |
| A01AC01 | triamcinolone | |
| A01AC02 | dexamethasone | |
| A01AC03 | hydrocortisone | |
| A01AC54 | prednisolone, combinations | |
| A01AD | Other agents for local oral treatment | |
| A01AD01 | epinephrine | |
| A01AD02 | benzydamine | |
| A01AD05 | acetylsalicylic acid | |
| A01AD06 | adrenalone | |
| A01AD07 | amlexanox | |
| A01AD08 | becaplermin | |
| A01AD11 | various | |
| A02 | DRUGS FOR ACID RELATED DISORDERS | |
| A02A | ANTACIDS | |
| A02AA | Magnesium compounds | |
| A02AA01 | magnesium carbonate | |
| A02AA02 | magnesium oxide | |
| A02AA03 | magnesium peroxide | |
| A02AA04 | magnesium hydroxide | |
| A02AA05 | magnesium silicate | |
| A02AA10 | combinations | |
| A02AB | Aluminium compounds | |
| A02AB01 | aluminium hydroxide | |
| A02AB02 | algeldrate | |
| A02AB03 | aluminium phosphate | |
| A02AB04 | dihydroxialumini sodium carbonate | |
| A02AB05 | aluminium acetoacetate | |
| A02AB06 | aloglutamol | |
| A02AB07 | aluminium glycinate | |
| A02AB10 | combinations | |
| A02AC | Calcium compounds | |
| A02AC01 | calcium carbonate | |
| A02AC02 | calcium silicate | |
| A02AC10 | combinations | |
| A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | |
| A02AD01 | ordinary salt combinations | |
| A02AD02 | magaldrate | |
| A02AD03 | almagate | |
| A02AD04 | hydrotalcite | |
| A02AD05 | almasilate | |
| A02AF | Antacids with antiflatulents | |
| A02AF01 | magaldrate and antiflatulents | |
| A02AF02 | ordinary salt combinations and antiflatulents | |
| A02AG | Antacids with antispasmodics | |
| A02AH | Antacids with sodium bicarbonate | |
| A02AX | Antacids, other combinations | |
| A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
| A02BA | H2-receptor antagonists | |
| A02BA01 | cimetidine | |
| A02BA02 | ranitidine | |
| A02BA03 | famotidine | |
| A02BA04 | nizatidine | |
| A02BA05 | niperotidine | |
| A02BA06 | roxatidine | |
| A02BA07 | ranitidine bismuth citrate | |
| A02BA08 | lafutidine | |
| A02BA51 | cimetidine, combinations | |
| A02BA53 | famotidine, combinations | |
| A02BB | Prostaglandins | |
| A02BB01 | misoprostol | |
| A02BB02 | enprostil | |
| A02BC | Proton pump inhibitors | |
| A02BC01 | omeprazole | |
| A02BC02 | pantoprazole | |
| A02BC03 | lansoprazole | |
| A02BC04 | rabeprazole | |
| A02BC05 | esomeprazole | |
| A02BC06 | dexlansoprazole | |
| A02BC07 | dexrabeprazole | |
| A02BC08 | vonoprazan | |
| A02BC53 | lansoprazole, combinations | |
| A02BC54 | rabeprazole, combinations | |
| A02BD | Combinations for eradication of Helicobacter pylori | |
| A02BD01 | omeprazole, amoxicillin and metronidazole | |
| A02BD02 | lansoprazole, tetracycline and metronidazole | |
| A02BD03 | lansoprazole, amoxicillin and metronidazole | |
| A02BD04 | pantoprazole, amoxicillin and clarithromycin | |
| A02BD05 | omeprazole, amoxicillin and clarithromycin | |
| A02BD06 | esomeprazole, amoxicillin and clarithromycin | |
| A02BD07 | lansoprazole, amoxicillin and clarithromycin | |
| A02BD08 | bismuth subcitrate, tetracycline and metronidazole | |
| A02BD09 | lansoprazole, clarithromycin and tinidazole | |
| A02BD10 | lansoprazole, amoxicillin and levofloxacin | |
| A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | |
| A02BD12 | rabeprazole, amoxicillin and clarithromycin | |
| A02BD13 | rabeprazole, amoxicillin and metronidazole | |
| A02BD14 | vonoprazan, amoxicillin and clarithromycin | |
| A02BD15 | vonoprazan, amoxicillin and metronidazole | |
| A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
| A02BX01 | carbenoxolone | |
| A02BX02 | sucralfate | |
| A02BX03 | pirenzepine | |
| A02BX04 | methiosulfonium chloride | |
| A02BX05 | bismuth subcitrate | |
| A02BX06 | proglumide | |
| A02BX07 | gefarnate | |
| A02BX08 | sulglicotide | |
| A02BX09 | acetoxolone | |
| A02BX10 | zolimidine | |
| A02BX11 | troxipide | |
| A02BX12 | bismuth subnitrate | |
| A02BX13 | alginic acid | |
| A02BX14 | rebamipide | |
| A02BX51 | carbenoxolone, combinations excl. psycholeptics | |
| A02BX71 | carbenoxolone, combinations with psycholeptics | |
| A02BX77 | gefarnate, combinations with psycholeptics | |
| A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | |
| A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
| A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | |
| A03AA | Synthetic anticholinergics, esters with tertiary amino group | |
| A03AA01 | oxyphencyclimine | |
| A03AA03 | camylofin | |
| A03AA04 | mebeverine | |
| A03AA05 | trimebutine | |
| A03AA06 | rociverine | |
| A03AA07 | dicycloverine | |
| A03AA08 | dihexyverine | |
| A03AA09 | difemerine | |
| A03AA30 | piperidolate | |
| A03AB | Synthetic anticholinergics, quaternary ammonium compounds | |
| A03AB01 | benzilone | |
| A03AB02 | glycopyrronium bromide | |
| A03AB03 | oxyphenonium | |
| A03AB04 | penthienate | |
| A03AB05 | propantheline | |
| A03AB06 | otilonium bromide | |
| A03AB07 | methantheline | |
| A03AB08 | tridihexethyl | |
| A03AB09 | isopropamide | |
| A03AB10 | hexocyclium | |
| A03AB11 | poldine | |
| A03AB12 | mepenzolate | |
| A03AB13 | bevonium | |
| A03AB14 | pipenzolate | |
| A03AB15 | diphemanil | |
| A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | |
| A03AB17 | tiemonium iodide | |
| A03AB18 | prifinium bromide | |
| A03AB19 | timepidium bromide | |
| A03AB21 | fenpiverinium | |
| A03AB53 | oxyphenonium, combinations | |
| A03AC | Synthetic antispasmodics, amides with tertiary amines | |
| A03AC02 | dimethylaminopropionylphenothiazine | |
| A03AC04 | nicofetamide | |
| A03AC05 | tiropramide | |
| A03AD | Papaverine and derivatives | |
| A03AD01 | papaverine | |
| A03AD02 | drotaverine | |
| A03AD30 | moxaverine | |
| A03AE | Serotonin receptor antagonists | |
| A03AE01 | alosetron | |
| A03AE03 | cilansetron | |
| A03AX | Other drugs for functional gastrointestinal disorders | |
| A03AX01 | fenpiprane | |
| A03AX02 | diisopromine | |
| A03AX03 | chlorbenzoxamine | |
| A03AX04 | pinaverium | |
| A03AX05 | fenoverine | |
| A03AX06 | idanpramine | |
| A03AX07 | proxazole | |
| A03AX08 | alverine | |
| A03AX09 | trepibutone | |
| A03AX10 | isometheptene | |
| A03AX11 | caroverine | |
| A03AX12 | phloroglucinol | |
| A03AX13 | silicones | |
| A03AX14 | valethamate | |
| A03AX15 | menthae piperitae aetheroleum | |
| A03AX30 | trimethyldiphenylpropylamine | |
| A03AX58 | alverine, combinations | |
| A03B | BELLADONNA AND DERIVATIVES, PLAIN | |
| A03BA | Belladonna alkaloids, tertiary amines | |
| A03BA01 | atropine | |
| A03BA03 | hyoscyamine | |
| A03BA04 | belladonna total alkaloids | |
| A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | |
| A03BB01 | butylscopolamine | |
| A03BB02 | methylatropine | |
| A03BB03 | methylscopolamine | |
| A03BB04 | fentonium | |
| A03BB05 | cimetropium bromide | |
| A03BB06 | homatropine methylbromide | |
| A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | |
| A03CA | Synthetic anticholinergic agents in combination with psycholeptics | |
| A03CA01 | isopropamide and psycholeptics | |
| A03CA02 | clidinium and psycholeptics | |
| A03CA03 | oxyphencyclimine and psycholeptics | |
| A03CA04 | otilonium bromide and psycholeptics | |
| A03CA05 | glycopyrronium bromide and psycholeptics | |
| A03CA06 | bevonium and psycholeptics | |
| A03CA07 | ambutonium and psycholeptics | |
| A03CA08 | diphemanil and psycholeptics | |
| A03CA09 | pipenzolate and psycholeptics | |
| A03CA30 | emepronium and psycholeptics | |
| A03CA34 | propantheline and psycholeptics | |
| A03CB | Belladonna and derivatives in combination with psycholeptics | |
| A03CB01 | methylscopolamine and psycholeptics | |
| A03CB02 | belladonna total alkaloids and psycholeptics | |
| A03CB03 | atropine and psycholeptics | |
| A03CB04 | homatropine methylbromide and psycholeptics | |
| A03CB31 | hyoscyamine and psycholeptics | |
| A03CC | Other antispasmodics in combination with psycholeptics | |
| A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | |
| A03DA | Synthetic anticholinergic agents in combination with analgesics | |
| A03DA01 | tropenzilone and analgesics | |
| A03DA02 | pitofenone and analgesics | |
| A03DA03 | bevonium and analgesics | |
| A03DA04 | ciclonium and analgesics | |
| A03DA05 | camylofin and analgesics | |
| A03DA06 | trospium and analgesics | |
| A03DA07 | tiemonium iodide and analgesics | |
| A03DB | Belladonna and derivatives in combination with analgesics | |
| A03DB04 | butylscopolamine and analgesics | |
| A03DC | Other antispasmodics in combination with analgesics | |
| A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | |
| A03EA | Antispasmodics, psycholeptics and analgesics in combination | |
| A03ED | Antispasmodics in combination with other drugs | |
| A03F | PROPULSIVES | |
| A03FA | Propulsives | |
| A03FA01 | metoclopramide | |
| A03FA02 | cisapride | |
| A03FA03 | domperidone | |
| A03FA04 | bromopride | |
| A03FA05 | alizapride | |
| A03FA06 | clebopride | |
| A03FA07 | itopride | |
| A03FA08 | cinitapride | |
| A03FA09 | mosapride | |
| A04 | ANTIEMETICS AND ANTINAUSEANTS | |
| A04A | ANTIEMETICS AND ANTINAUSEANTS | |
| A04AA | Serotonin (5HT3) antagonists | |
| A04AA01 | ondansetron | |
| A04AA02 | granisetron | |
| A04AA03 | tropisetron | |
| A04AA04 | dolasetron | |
| A04AA05 | palonosetron | |
| A04AA55 | palonosetron, combinations | |
| A04AD | Other antiemetics | |
| A04AD01 | scopolamine | |
| A04AD02 | cerium oxalate | |
| A04AD04 | chlorobutanol | |
| A04AD05 | metopimazine | |
| A04AD10 | dronabinol | |
| A04AD11 | nabilone | |
| A04AD12 | aprepitant | |
| A04AD13 | casopitant | |
| A04AD14 | rolapitant | |
| A04AD51 | scopolamine, combinations | |
| A04AD54 | chlorobutanol, combinations | |
| A05 | BILE AND LIVER THERAPY | |
| A05A | BILE THERAPY | |
| A05AA | Bile acids and derivatives | |
| A05AA01 | chenodeoxycholic acid | |
| A05AA02 | ursodeoxycholic acid | |
| A05AA03 | cholic acid | |
| A05AA04 | obeticholic acid | |
| A05AB | Preparations for biliary tract therapy | |
| A05AB01 | nicotinyl methylamide | |
| A05AX | Other drugs for bile therapy | |
| A05AX01 | piprozolin | |
| A05AX02 | hymecromone | |
| A05AX03 | cyclobutyrol | |
| A05B | LIVER THERAPY, LIPOTROPICS | |
| A05BA | Liver therapy | |
| A05BA01 | arginine glutamate | |
| A05BA03 | silymarin | |
| A05BA04 | citiolone | |
| A05BA05 | epomediol | |
| A05BA06 | ornithine oxoglurate | |
| A05BA07 | tidiacic arginine | |
| A05BA08 | glycyrrhizic acid | |
| A05BA09 | metadoxine | |
| A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION | |
| A06 | DRUGS FOR CONSTIPATION | |
| A06A | DRUGS FOR CONSTIPATION | |
| A06AA | Softeners, emollients | |
| A06AA01 | liquid paraffin | |
| A06AA02 | docusate sodium | |
| A06AA51 | liquid paraffin, combinations | |
| A06AB | Contact laxatives | |
| A06AB01 | oxyphenisatine | |
| A06AB02 | bisacodyl | |
| A06AB03 | dantron | |
| A06AB04 | phenolphthalein | |
| A06AB05 | castor oil | |
| A06AB06 | senna glycosides | |
| A06AB07 | cascara | |
| A06AB08 | sodium picosulfate | |
| A06AB09 | bisoxatin | |
| A06AB20 | contact laxatives in combination | |
| A06AB30 | contact laxatives in combination with belladonna alkaloids | |
| A06AB52 | bisacodyl, combinations | |
| A06AB53 | dantron, combinations | |
| A06AB56 | senna glycosides, combinations | |
| A06AB57 | cascara, combinations | |
| A06AB58 | sodium picosulfate, combinations | |
| A06AC | Bulk-forming laxatives | |
| A06AC01 | ispaghula (psylla seeds) | |
| A06AC02 | ethulose | |
| A06AC03 | sterculia | |
| A06AC05 | linseed | |
| A06AC06 | methylcellulose | |
| A06AC07 | triticum (wheat fibre) | |
| A06AC08 | polycarbophil calcium | |
| A06AC51 | ispaghula, combinations | |
| A06AC53 | sterculia, combinations | |
| A06AC55 | linseed, combinations | |
| A06AD | Osmotically acting laxatives | |
| A06AD01 | magnesium carbonate | |
| A06AD02 | magnesium oxide | |
| A06AD03 | magnesium peroxide | |
| A06AD04 | magnesium sulfate | |
| A06AD10 | mineral salts in combination | |
| A06AD11 | lactulose | |
| A06AD12 | lactitol | |
| A06AD13 | sodium sulfate | |
| A06AD14 | pentaerithrityl | |
| A06AD15 | macrogol | |
| A06AD16 | mannitol | |
| A06AD17 | sodium phosphate | |
| A06AD18 | sorbitol | |
| A06AD19 | magnesium citrate | |
| A06AD21 | sodium tartrate | |
| A06AD61 | lactulose, combinations | |
| A06AD65 | macrogol, combinations | |
| A06AG | Enemas | |
| A06AG01 | sodium phosphate | |
| A06AG02 | bisacodyl | |
| A06AG03 | dantron, incl. combinations | |
| A06AG04 | glycerol | |
| A06AG06 | oil | |
| A06AG07 | sorbitol | |
| A06AG10 | docusate sodium, incl. combinations | |
| A06AG11 | sodium lauryl sulfoacetate, incl. combinations | |
| A06AG20 | combinations | |
| A06AH | Peripheral opioid receptor antagonists | |
| A06AH01 | methylnaltrexone bromide | |
| A06AH02 | alvimopan | |
| A06AH03 | naloxegol | |
| A06AH04 | naloxone | |
| A06AH05 | naldemedine | |
| A06AX | Other drugs for constipation | |
| A06AX01 | glycerol | |
| A06AX02 | carbon dioxide producing drugs | |
| A06AX03 | lubiprostone | |
| A06AX04 | linaclotide | |
| A06AX05 | prucalopride | |
| A06AX06 | tegaserod | |
| A06AX07 | plecanatide | |
| A06AX08 | tenapanor | |
| A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | |
| A07A | INTESTINAL ANTIINFECTIVES | |
| A07AA | Antibiotics | |
| A07AA01 | neomycin | |
| A07AA02 | nystatin | |
| A07AA03 | natamycin | |
| A07AA04 | streptomycin | |
| A07AA05 | polymyxin B | |
| A07AA06 | paromomycin | |
| A07AA07 | amphotericin B | |
| A07AA08 | kanamycin | |
| A07AA09 | vancomycin | |
| A07AA10 | colistin | |
| A07AA11 | rifaximin | |
| A07AA12 | fidaxomicin | |
| A07AA13 | rifamycin | |
| A07AA51 | neomycin, combinations | |
| A07AA54 | streptomycin, combinations | |
| A07AB | Sulfonamides | |
| A07AB02 | phthalylsulfathiazole | |
| A07AB03 | sulfaguanidine | |
| A07AB04 | succinylsulfathiazole | |
| A07AC | Imidazole derivatives | |
| A07AC01 | miconazole | |
| A07AX | Other intestinal antiinfectives | |
| A07AX01 | broxyquinoline | |
| A07AX02 | acetarsol | |
| A07AX03 | nifuroxazide | |
| A07AX04 | nifurzide | |
| A07B | INTESTINAL ADSORBENTS | |
| A07BA | Charcoal preparations | |
| A07BA01 | medicinal charcoal | |
| A07BA51 | medicinal charcoal, combinations | |
| A07BB | Bismuth preparations | |
| A07BC | Other intestinal adsorbents | |
| A07BC01 | pectin | |
| A07BC02 | kaolin | |
| A07BC03 | crospovidone | |
| A07BC04 | attapulgite | |
| A07BC05 | diosmectite | |
| A07BC30 | combinations | |
| A07BC54 | attapulgite, combinations | |
| A07C | ELECTROLYTES WITH CARBOHYDRATES | |
| A07CA | Oral rehydration salt formulations | |
| A07D | ANTIPROPULSIVES | |
| A07DA | Antipropulsives | |
| A07DA01 | diphenoxylate | |
| A07DA02 | opium | |
| A07DA03 | loperamide | |
| A07DA04 | difenoxin | |
| A07DA05 | loperamide oxide | |
| A07DA06 | eluxadoline | |
| A07DA52 | morphine, combinations | |
| A07DA53 | loperamide, combinations | |
| A07E | INTESTINAL ANTIINFLAMMATORY AGENTS | |
| A07EA | Corticosteroids acting locally | |
| A07EA01 | prednisolone | |
| A07EA02 | hydrocortisone | |
| A07EA03 | prednisone | |
| A07EA04 | betamethasone | |
| A07EA05 | tixocortol | |
| A07EA06 | budesonide | |
| A07EA07 | beclometasone | |
| A07EB | Antiallergic agents, excl. corticosteroids | |
| A07EB01 | cromoglicic acid | |
| A07EC | Aminosalicylic acid and similar agents | |
| A07EC01 | sulfasalazine | |
| A07EC02 | mesalazine | |
| A07EC03 | olsalazine | |
| A07EC04 | balsalazide | |
| A07F | ANTIDIARRHEAL MICROORGANISMS | |
| A07FA | Antidiarrheal microorganisms | |
| A07FA01 | lactic acid producing organisms | |
| A07FA02 | saccharomyces boulardii | |
| A07FA51 | lactic acid producing organisms, combinations | |
| A07X | OTHER ANTIDIARRHEALS | |
| A07XA | Other antidiarrheals | |
| A07XA01 | albumin tannate | |
| A07XA02 | ceratonia | |
| A07XA03 | calcium compounds | |
| A07XA04 | racecadotril | |
| A07XA06 | crofelemer | |
| A07XA51 | albumin tannate, combinations | |
| A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | |
| A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | |
| A08AA | Centrally acting antiobesity products | |
| A08AA01 | phentermine | |
| A08AA02 | fenfluramine | |
| A08AA03 | amfepramone | |
| A08AA04 | dexfenfluramine | |
| A08AA05 | mazindol | |
| A08AA06 | etilamfetamine | |
| A08AA07 | cathine | |
| A08AA08 | clobenzorex | |
| A08AA09 | mefenorex | |
| A08AA10 | sibutramine | |
| A08AA11 | lorcaserin | |
| A08AA56 | ephedrine, combinations | |
| A08AA62 | bupropion and naltrexone | |
| A08AB | Peripherally acting antiobesity products | |
| A08AB01 | orlistat | |
| A08AX | Other antiobesity drugs | |
| A08AX01 | rimonabant | |
| A09 | DIGESTIVES, INCL. ENZYMES | |
| A09A | DIGESTIVES, INCL. ENZYMES | |
| A09AA | Enzyme preparations | |
| A09AA01 | diastase | |
| A09AA02 | multienzymes (lipase, protease etc.) | |
| A09AA03 | pepsin | |
| A09AA04 | tilactase | |
| A09AB | Acid preparations | |
| A09AB01 | glutamic acid hydrochloride | |
| A09AB02 | betaine hydrochloride | |
| A09AB03 | hydrochloric acid | |
| A09AB04 | citric acid | |
| A09AC | Enzyme and acid preparations, combinations | |
| A09AC01 | pepsin and acid preparations | |
| A09AC02 | multienzymes and acid preparations | |
| A10 | DRUGS USED IN DIABETES | |
| A10A | INSULINS AND ANALOGUES | |
| A10AB | Insulins and analogues for injection, fast-acting | |
| A10AB01 | insulin (human) | |
| A10AB02 | insulin (beef) | |
| A10AB03 | insulin (pork) | |
| A10AB04 | insulin lispro | |
| A10AB05 | insulin aspart | |
| A10AB06 | insulin glulisine | |
| A10AB30 | combinations | |
| A10AC | Insulins and analogues for injection, intermediate-acting | |
| A10AC01 | insulin (human) | |
| A10AC02 | insulin (beef) | |
| A10AC03 | insulin (pork) | |
| A10AC04 | insulin lispro | |
| A10AC30 | combinations | |
| A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | |
| A10AD01 | insulin (human) | |
| A10AD02 | insulin (beef) | |
| A10AD03 | insulin (pork) | |
| A10AD04 | insulin lispro | |
| A10AD05 | insulin aspart | |
| A10AD06 | insulin degludec and insulin aspart | |
| A10AD30 | combinations | |
| A10AE | Insulins and analogues for injection, long-acting | |
| A10AE01 | insulin (human) | |
| A10AE02 | insulin (beef) | |
| A10AE03 | insulin (pork) | |
| A10AE04 | insulin glargine | |
| A10AE05 | insulin detemir | |
| A10AE06 | insulin degludec | |
| A10AE30 | combinations | |
| A10AE54 | insulin glargine and lixisenatide | |
| A10AE56 | insulin degludec and liraglutide | |
| A10AF | Insulins and analogues for inhalation | |
| A10AF01 | insulin (human) | |
| A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | |
| A10BA | Biguanides | |
| A10BA01 | phenformin | |
| A10BA02 | metformin | |
| A10BA03 | buformin | |
| A10BB | Sulfonylureas | |
| A10BB01 | glibenclamide | |
| A10BB02 | chlorpropamide | |
| A10BB03 | tolbutamide | |
| A10BB04 | glibornuride | |
| A10BB05 | tolazamide | |
| A10BB06 | carbutamide | |
| A10BB07 | glipizide | |
| A10BB08 | gliquidone | |
| A10BB09 | gliclazide | |
| A10BB10 | metahexamide | |
| A10BB11 | glisoxepide | |
| A10BB12 | glimepiride | |
| A10BB31 | acetohexamide | |
| A10BC | Sulfonamides (heterocyclic) | |
| A10BC01 | glymidine | |
| A10BD | Combinations of oral blood glucose lowering drugs | |
| A10BD01 | phenformin and sulfonylureas | |
| A10BD02 | metformin and sulfonylureas | |
| A10BD03 | metformin and rosiglitazone | |
| A10BD04 | glimepiride and rosiglitazone | |
| A10BD05 | metformin and pioglitazone | |
| A10BD06 | glimepiride and pioglitazone | |
| A10BD07 | metformin and sitagliptin | |
| A10BD08 | metformin and vildagliptin | |
| A10BD09 | pioglitazone and alogliptin | |
| A10BD10 | metformin and saxagliptin | |
| A10BD11 | metformin and linagliptin | |
| A10BD12 | pioglitazone and sitagliptin | |
| A10BD13 | metformin and alogliptin | |
| A10BD14 | metformin and repaglinide | |
| A10BD15 | metformin and dapagliflozin | |
| A10BD16 | metformin and canagliflozin | |
| A10BD17 | metformin and acarbose | |
| A10BD18 | metformin and gemigliptin | |
| A10BD19 | linagliptin and empagliflozin | |
| A10BD20 | metformin and empagliflozin | |
| A10BD21 | saxagliptin and dapagliflozin | |
| A10BD22 | metformin and evogliptin | |
| A10BD23 | metformin and ertugliflozin | |
| A10BD24 | sitagliptin and ertugliflozin | |
| A10BD25 | metformin, saxagliptin and dapagliflozin | |
| A10BD26 | metformin and lobeglitazone | |
| A10BF | Alpha glucosidase inhibitors | |
| A10BF01 | acarbose | |
| A10BF02 | miglitol | |
| A10BF03 | voglibose | |
| A10BG | Thiazolidinediones | |
| A10BG01 | troglitazone | |
| A10BG02 | rosiglitazone | |
| A10BG03 | pioglitazone | |
| A10BG04 | lobeglitazone | |
| A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | |
| A10BH01 | sitagliptin | |
| A10BH02 | vildagliptin | |
| A10BH03 | saxagliptin | |
| A10BH04 | alogliptin | |
| A10BH05 | linagliptin | |
| A10BH06 | gemigliptin | |
| A10BH07 | evogliptin | |
| A10BH08 | teneligliptin | |
| A10BH51 | sitagliptin and simvastatin | |
| A10BH52 | gemigliptin and rosuvastatin | |
| A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | |
| A10BJ01 | exenatide | |
| A10BJ02 | liraglutide | |
| A10BJ03 | lixisenatide | |
| A10BJ04 | albiglutide | |
| A10BJ05 | dulaglutide | |
| A10BJ06 | semaglutide | |
| A10BJ07 | beinaglutide | |
| A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | |
| A10BK01 | dapagliflozin | |
| A10BK02 | canagliflozin | |
| A10BK03 | empagliflozin | |
| A10BK04 | ertugliflozin | |
| A10BK05 | ipragliflozin | |
| A10BK06 | sotagliflozin | |
| A10BK07 | luseogliflozin | |
| A10BX | Other blood glucose lowering drugs, excl. insulins | |
| A10BX01 | guar gum | |
| A10BX02 | repaglinide | |
| A10BX03 | nateglinide | |
| A10BX05 | pramlintide | |
| A10BX06 | benfluorex | |
| A10BX08 | mitiglinide | |
| A10X | OTHER DRUGS USED IN DIABETES | |
| A10XA | Aldose reductase inhibitors | |
| A10XA01 | tolrestat | |
| A11 | VITAMINS | |
| A11A | MULTIVITAMINS, COMBINATIONS | |
| A11AA | Multivitamins with minerals | |
| A11AA01 | multivitamins and iron | |
| A11AA02 | multivitamins and calcium | |
| A11AA03 | multivitamins and other minerals, incl. combinations | |
| A11AA04 | multivitamins and trace elements | |
| A11AB | Multivitamins, other combinations | |
| A11B | MULTIVITAMINS, PLAIN | |
| A11BA | Multivitamins, plain | |
| A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | |
| A11CA | Vitamin A, plain | |
| A11CA01 | retinol (vit A) | |
| A11CA02 | betacarotene | |
| A11CB | Vitamin A and D in combination | |
| A11CC | Vitamin D and analogues | |
| A11CC01 | ergocalciferol | |
| A11CC02 | dihydrotachysterol | |
| A11CC03 | alfacalcidol | |
| A11CC04 | calcitriol | |
| A11CC05 | colecalciferol | |
| A11CC06 | calcifediol | |
| A11CC20 | combinations | |
| A11CC55 | colecalciferol, combinations | |
| A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 | |
| A11DA | Vitamin B1, plain | |
| A11DA01 | thiamine (vit B1) | |
| A11DA02 | sulbutiamine | |
| A11DA03 | benfotiamine | |
| A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | |
| A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS | |
| A11EA | Vitamin B-complex, plain | |
| A11EB | Vitamin B-complex with vitamin C | |
| A11EC | Vitamin B-complex with minerals | |
| A11ED | Vitamin B-complex with anabolic steroids | |
| A11EX | Vitamin B-complex, other combinations | |
| A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS | |
| A11GA | Ascorbic acid (vitamin C), plain | |
| A11GA01 | ascorbic acid (vit C) | |
| A11GB | Ascorbic acid (vitamin C), combinations | |
| A11GB01 | ascorbic acid (vit C) and calcium | |
| A11H | OTHER PLAIN VITAMIN PREPARATIONS | |
| A11HA | Other plain vitamin preparations | |
| A11HA01 | nicotinamide | |
| A11HA02 | pyridoxine (vit B6) | |
| A11HA03 | tocopherol (vit E) | |
| A11HA04 | riboflavin (vit B2) | |
| A11HA05 | biotin | |
| A11HA06 | pyridoxal phosphate | |
| A11HA07 | inositol | |
| A11HA08 | tocofersolan | |
| A11HA30 | dexpanthenol | |
| A11HA31 | calcium pantothenate | |
| A11HA32 | pantethine | |
| A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS | |
| A11JA | Combinations of vitamins | |
| A11JB | Vitamins with minerals | |
| A11JC | Vitamins, other combinations | |
| A12 | MINERAL SUPPLEMENTS | |
| A12A | CALCIUM | |
| A12AA | Calcium | |
| A12AA01 | calcium phosphate | |
| A12AA02 | calcium glubionate | |
| A12AA03 | calcium gluconate | |
| A12AA04 | calcium carbonate | |
| A12AA05 | calcium lactate | |
| A12AA06 | calcium lactate gluconate | |
| A12AA07 | calcium chloride | |
| A12AA08 | calcium glycerylphosphate | |
| A12AA09 | calcium citrate lysine complex | |
| A12AA10 | calcium glucoheptonate | |
| A12AA11 | calcium pangamate | |
| A12AA13 | calcium citrate | |
| A12AA20 | calcium (different salts in combination) | |
| A12AA30 | calcium laevulate | |
| A12AX | Calcium, combinations with vitamin D and/or other drugs | |
| A12B | POTASSIUM | |
| A12BA | Potassium | |
| A12BA01 | potassium chloride | |
| A12BA02 | potassium citrate | |
| A12BA03 | potassium hydrogentartrate | |
| A12BA04 | potassium hydrogencarbonate | |
| A12BA05 | potassium gluconate | |
| A12BA30 | potassium (different salts in combination) | |
| A12BA51 | potassium chloride, combinations | |
| A12C | OTHER MINERAL SUPPLEMENTS | |
| A12CA | Sodium | |
| A12CA01 | sodium chloride | |
| A12CA02 | sodium sulfate | |
| A12CB | Zinc | |
| A12CB01 | zinc sulfate | |
| A12CB02 | zinc gluconate | |
| A12CB03 | zinc protein complex | |
| A12CC | Magnesium | |
| A12CC01 | magnesium chloride | |
| A12CC02 | magnesium sulfate | |
| A12CC03 | magnesium gluconate | |
| A12CC04 | magnesium citrate | |
| A12CC05 | magnesium aspartate | |
| A12CC06 | magnesium lactate | |
| A12CC07 | magnesium levulinate | |
| A12CC08 | magnesium pidolate | |
| A12CC09 | magnesium orotate | |
| A12CC10 | magnesium oxide | |
| A12CC30 | magnesium (different salts in combination) | |
| A12CD | Fluoride | |
| A12CD01 | sodium fluoride | |
| A12CD02 | sodium monofluorophosphate | |
| A12CD51 | fluoride, combinations | |
| A12CE | Selenium | |
| A12CE01 | sodium selenate | |
| A12CE02 | sodium selenite | |
| A12CX | Other mineral products | |
| A13 | TONICS | |
| A13A | TONICS | |
| A14 | ANABOLIC AGENTS FOR SYSTEMIC USE | |
| A14A | ANABOLIC STEROIDS | |
| A14AA | Androstan derivatives | |
| A14AA01 | androstanolone | |
| A14AA02 | stanozolol | |
| A14AA03 | metandienone | |
| A14AA04 | metenolone | |
| A14AA05 | oxymetholone | |
| A14AA06 | quinbolone | |
| A14AA07 | prasterone | |
| A14AA08 | oxandrolone | |
| A14AA09 | norethandrolone | |
| A14AB | Estren derivatives | |
| A14AB01 | nandrolone | |
| A14AB02 | ethylestrenol | |
| A14AB03 | oxabolone cipionate | |
| A14B | OTHER ANABOLIC AGENTS | |
| A15 | APPETITE STIMULANTS | |
| A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |
| A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | |
| A16AA | Amino acids and derivatives | |
| A16AA01 | levocarnitine | |
| A16AA02 | ademetionine | |
| A16AA03 | glutamine | |
| A16AA04 | mercaptamine | |
| A16AA05 | carglumic acid | |
| A16AA06 | betaine | |
| A16AA07 | metreleptin | |
| A16AB | Enzymes | |
| A16AB01 | alglucerase | |
| A16AB02 | imiglucerase | |
| A16AB03 | agalsidase alfa | |
| A16AB04 | agalsidase beta | |
| A16AB05 | laronidase | |
| A16AB06 | sacrosidase | |
| A16AB07 | alglucosidase alfa | |
| A16AB08 | galsulfase | |
| A16AB09 | idursulfase | |
| A16AB10 | velaglucerase alfa | |
| A16AB11 | taliglucerase alfa | |
| A16AB12 | elosulfase alfa | |
| A16AB13 | asfotase alfa | |
| A16AB14 | sebelipase alfa | |
| A16AB15 | velmanase alfa | |
| A16AB16 | idursulfase beta | |
| A16AB17 | cerliponase alfa | |
| A16AB18 | vestronidase alfa | |
| A16AB19 | pegvaliase | |
| A16AX | Various alimentary tract and metabolism products | |
| A16AX01 | thioctic acid | |
| A16AX02 | anethole trithione | |
| A16AX03 | sodium phenylbutyrate | |
| A16AX04 | nitisinone | |
| A16AX05 | zinc acetate | |
| A16AX06 | miglustat | |
| A16AX07 | sapropterin | |
| A16AX08 | teduglutide | |
| A16AX09 | glycerol phenylbutyrate | |
| A16AX10 | eliglustat | |
| A16AX11 | sodium benzoate | |
| A16AX12 | trientine | |
| A16AX13 | uridine triacetate | |
| A16AX14 | migalastat | |
| A16AX15 | telotristat | |
| A16AX16 | givosiran | |
| A16AX17 | triheptanoin | |
| A16AX18 | lumasiran | |
| A16AX30 | sodium benzoate and sodium phenylacetate | |
| B | BLOOD AND BLOOD FORMING ORGANS | |
| B01 | ANTITHROMBOTIC AGENTS | |
| B01A | ANTITHROMBOTIC AGENTS | |
| B01AA | Vitamin K antagonists | |
| B01AA01 | dicoumarol | |
| B01AA02 | phenindione | |
| B01AA03 | warfarin | |
| B01AA04 | phenprocoumon | |
| B01AA07 | acenocoumarol | |
| B01AA08 | ethyl biscoumacetate | |
| B01AA09 | clorindione | |
| B01AA10 | diphenadione | |
| B01AA11 | tioclomarol | |
| B01AA12 | fluindione | |
| B01AB | Heparin group | |
| B01AB01 | heparin | |
| B01AB02 | antithrombin III | |
| B01AB04 | dalteparin | |
| B01AB05 | enoxaparin | |
| B01AB06 | nadroparin | |
| B01AB07 | parnaparin | |
| B01AB08 | reviparin | |
| B01AB09 | danaparoid | |
| B01AB10 | tinzaparin | |
| B01AB11 | sulodexide | |
| B01AB12 | bemiparin | |
| B01AB51 | heparin, combinations | |
| B01AC | Platelet aggregation inhibitors excl. heparin | |
| B01AC01 | ditazole | |
| B01AC02 | cloricromen | |
| B01AC03 | picotamide | |
| B01AC04 | clopidogrel | |
| B01AC05 | ticlopidine | |
| B01AC06 | acetylsalicylic acid | |
| B01AC07 | dipyridamole | |
| B01AC08 | carbasalate calcium | |
| B01AC09 | epoprostenol | |
| B01AC10 | indobufen | |
| B01AC11 | iloprost | |
| B01AC13 | abciximab | |
| B01AC15 | aloxiprin | |
| B01AC16 | eptifibatide | |
| B01AC17 | tirofiban | |
| B01AC18 | triflusal | |
| B01AC19 | beraprost | |
| B01AC21 | treprostinil | |
| B01AC22 | prasugrel | |
| B01AC23 | cilostazol | |
| B01AC24 | ticagrelor | |
| B01AC25 | cangrelor | |
| B01AC26 | vorapaxar | |
| B01AC27 | selexipag | |
| B01AC30 | combinations | |
| B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors | |
| B01AD | Enzymes | |
| B01AD01 | streptokinase | |
| B01AD02 | alteplase | |
| B01AD03 | anistreplase | |
| B01AD04 | urokinase | |
| B01AD05 | fibrinolysin | |
| B01AD06 | brinase | |
| B01AD07 | reteplase | |
| B01AD08 | saruplase | |
| B01AD09 | ancrod | |
| B01AD10 | drotrecogin alfa (activated) | |
| B01AD11 | tenecteplase | |
| B01AD12 | protein C | |
| B01AE | Direct thrombin inhibitors | |
| B01AE01 | desirudin | |
| B01AE02 | lepirudin | |
| B01AE03 | argatroban | |
| B01AE04 | melagatran | |
| B01AE05 | ximelagatran | |
| B01AE06 | bivalirudin | |
| B01AE07 | dabigatran etexilate | |
| B01AF | Direct factor Xa inhibitors | |
| B01AF01 | rivaroxaban | |
| B01AF02 | apixaban | |
| B01AF03 | edoxaban | |
| B01AF04 | betrixaban | |
| B01AX | Other antithrombotic agents | |
| B01AX01 | defibrotide | |
| B01AX04 | dermatan sulfate | |
| B01AX05 | fondaparinux | |
| B01AX07 | caplacizumab | |
| B02 | ANTIHEMORRHAGICS | |
| B02A | ANTIFIBRINOLYTICS | |
| B02AA | Amino acids | |
| B02AA01 | aminocaproic acid | |
| B02AA02 | tranexamic acid | |
| B02AA03 | aminomethylbenzoic acid | |
| B02AB | Proteinase inhibitors | |
| B02AB01 | aprotinin | |
| B02AB02 | alfa1 antitrypsin | |
| B02AB04 | camostat | |
| B02AB05 | ulinastatin | |
| B02B | VITAMIN K AND OTHER HEMOSTATICS | |
| B02BA | Vitamin K | |
| B02BA01 | phytomenadione | |
| B02BA02 | menadione | |
| B02BB | Fibrinogen | |
| B02BB01 | fibrinogen, human | |
| B02BC | Local hemostatics | |
| B02BC01 | absorbable gelatin sponge | |
| B02BC02 | oxidized cellulose | |
| B02BC03 | tetragalacturonic acid hydroxymethylester | |
| B02BC05 | adrenalone | |
| B02BC06 | thrombin | |
| B02BC07 | collagen | |
| B02BC08 | calcium alginate | |
| B02BC09 | epinephrine | |
| B02BC30 | combinations | |
| B02BD | Blood coagulation factors | |
| B02BD01 | coagulation factor IX, II, VII and X in combination | |
| B02BD02 | coagulation factor VIII | |
| B02BD03 | factor VIII inhibitor bypassing activity | |
| B02BD04 | coagulation factor IX | |
| B02BD05 | coagulation factor VII | |
| B02BD06 | von Willebrand factor and coagulation factor VIII in combination | |
| B02BD07 | coagulation factor XIII | |
| B02BD08 | coagulation factor VIIa | |
| B02BD10 | von Willebrand factor | |
| B02BD11 | catridecacog | |
| B02BD13 | coagulation factor X | |
| B02BD14 | susoctocog alfa | |
| B02BD30 | thrombin | |
| B02BX | Other systemic hemostatics | |
| B02BX01 | etamsylate | |
| B02BX02 | carbazochrome | |
| B02BX03 | batroxobin | |
| B02BX04 | romiplostim | |
| B02BX05 | eltrombopag | |
| B02BX06 | emicizumab | |
| B02BX07 | lusutrombopag | |
| B02BX08 | avatrombopag | |
| B02BX09 | fostamatinib | |
| B03 | ANTIANEMIC PREPARATIONS | |
| B03A | IRON PREPARATIONS | |
| B03AA | Iron bivalent, oral preparations | |
| B03AA01 | ferrous glycine sulfate | |
| B03AA02 | ferrous fumarate | |
| B03AA03 | ferrous gluconate | |
| B03AA04 | ferrous carbonate | |
| B03AA05 | ferrous chloride | |
| B03AA06 | ferrous succinate | |
| B03AA07 | ferrous sulfate | |
| B03AA08 | ferrous tartrate | |
| B03AA09 | ferrous aspartate | |
| B03AA10 | ferrous ascorbate | |
| B03AA11 | ferrous iodine | |
| B03AA12 | ferrous sodium citrate | |
| B03AB | Iron trivalent, oral preparations | |
| B03AB01 | ferric sodium citrate | |
| B03AB02 | saccharated iron oxide | |
| B03AB03 | sodium feredetate | |
| B03AB04 | ferric hydroxide | |
| B03AB05 | ferric oxide polymaltose complexes | |
| B03AB07 | chondroitin sulfate-iron complex | |
| B03AB08 | ferric acetyl transferrin | |
| B03AB09 | ferric proteinsuccinylate | |
| B03AB10 | ferric maltol | |
| B03AC | Iron, parenteral preparations | |
| B03AD | Iron in combination with folic acid | |
| B03AD01 | ferrous amino acid complex | |
| B03AD02 | ferrous fumarate | |
| B03AD03 | ferrous sulfate | |
| B03AD04 | ferric oxide polymaltose complexes | |
| B03AD05 | ferrous gluconate | |
| B03AE | Iron in other combinations | |
| B03AE01 | iron, vitamin B12 and folic acid | |
| B03AE02 | iron, multivitamins and folic acid | |
| B03AE03 | iron and multivitamins | |
| B03AE04 | iron, multivitamins and minerals | |
| B03AE10 | various combinations | |
| B03B | VITAMIN B12 AND FOLIC ACID | |
| B03BA | Vitamin B12 (cyanocobalamin and analogues) | |
| B03BA01 | cyanocobalamin | |
| B03BA02 | cyanocobalamin tannin complex | |
| B03BA03 | hydroxocobalamin | |
| B03BA04 | cobamamide | |
| B03BA05 | mecobalamin | |
| B03BA51 | cyanocobalamin, combinations | |
| B03BA53 | hydroxocobalamin, combinations | |
| B03BB | Folic acid and derivatives | |
| B03BB01 | folic acid | |
| B03BB51 | folic acid, combinations | |
jurisdiction[0]